MrMed announces significant expansion of infrastructure in Bengaluru

For patients managing cancer, autoimmune conditions, or complex metabolic disorders, reliable access to specialty medicines is not a convenience but a clinical necessity. Chennai-based startup MrMed, India's specialty and super-specialty medicine platform, is making a significant infrastructure bet on Bengaluru — among its top two revenue markets, as part of a broader strategy to deepen access to critical care medicines, expanding last-mile reach, improving delivery timelines, and strengthening supply reliability across one of its most active demand clusters.

At the centre of this expansion is a new storage and distribution hub in Central Bengaluru, an 850 sq ft facility strategically located for rapid dispatch across the city, including areas that have historically seen limited access to specialty medicines.

Complementing this is MrMed’s 2,000+ sq ft Bengaluru office, which functions as a central command centre overseeing operations not just for the city hub but coordinating fulfilment, supply, and service workflows across the country. 

The development is complemented by deeper sourcing partnerships with local distributors and manufacturers, technology-driven improvements across order processing, billing, and dispatch, and last-mile delivery capabilities. Together, they have enabled MrMed to offer 24-hour delivery across approximately 110 pincodes (560001 to 562162), covering the majority of its catalogue — including oncology drugs, immunosuppressants, and GLP-1 therapies such as semaglutide and tirzepatide.

"Bengaluru is one of our largest target markets which makes it the natural starting point for this level of investment," said Devashish Singh, Co-Founder & CEO, MrMed. "The operational challenge was never just speed — it was ensuring consistency across the entire order lifecycle, from real-time availability to last-mile delivery, at scale. What we've built here is a model we intend to replicate city by city."

The company is now working to roll out this model in Delhi and Chennai, followed by Guwahati, Mumbai and Hyderabad. MrMed expects to achieve complete geographic coverage within Bengaluru over the next 1-2 months.